PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
MORF vs. LABU
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Key characteristics


MORFLABU

Correlation

-0.50.00.51.00.6

The correlation between MORF and LABU is 0.56, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.

Performance

MORF vs. LABU - Performance Comparison

The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


-20.00%0.00%20.00%40.00%60.00%80.00%JuneJulyAugustSeptemberOctoberNovember
75.62%
0.80%
MORF
LABU

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

MORF vs. LABU - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Morphic Holding, Inc. (MORF) and Direxion Daily S&P Biotech Bull 3x Shares (LABU). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


MORF
Sharpe ratio
The chart of Sharpe ratio for MORF, currently valued at 1.72, compared to the broader market-4.00-2.000.002.004.001.72
Sortino ratio
The chart of Sortino ratio for MORF, currently valued at 4.08, compared to the broader market-4.00-2.000.002.004.006.004.08
Omega ratio
The chart of Omega ratio for MORF, currently valued at 1.59, compared to the broader market0.501.001.502.001.59
Calmar ratio
The chart of Calmar ratio for MORF, currently valued at 2.07, compared to the broader market0.002.004.006.002.07
Martin ratio
The chart of Martin ratio for MORF, currently valued at 10.28, compared to the broader market0.0010.0020.0030.0010.28
LABU
Sharpe ratio
The chart of Sharpe ratio for LABU, currently valued at 1.07, compared to the broader market-4.00-2.000.002.004.001.07
Sortino ratio
The chart of Sortino ratio for LABU, currently valued at 1.77, compared to the broader market-4.00-2.000.002.004.006.001.77
Omega ratio
The chart of Omega ratio for LABU, currently valued at 1.20, compared to the broader market0.501.001.502.001.20
Calmar ratio
The chart of Calmar ratio for LABU, currently valued at 0.85, compared to the broader market0.002.004.006.000.85
Martin ratio
The chart of Martin ratio for LABU, currently valued at 3.16, compared to the broader market0.0010.0020.0030.003.16

MORF vs. LABU - Sharpe Ratio Comparison


Rolling 12-month Sharpe Ratio-0.500.000.501.001.502.00JuneJulyAugustSeptemberOctoberNovember
1.72
1.07
MORF
LABU

Dividends

MORF vs. LABU - Dividend Comparison

MORF has not paid dividends to shareholders, while LABU's dividend yield for the trailing twelve months is around 0.44%.


TTM2023202220212020201920182017
MORF
Morphic Holding, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
LABU
Direxion Daily S&P Biotech Bull 3x Shares
0.44%0.35%0.00%0.00%0.00%0.28%0.64%0.17%

Drawdowns

MORF vs. LABU - Drawdown Comparison


-100.00%-90.00%-80.00%-70.00%-60.00%-50.00%-40.00%-30.00%JuneJulyAugustSeptemberOctoberNovember
-32.83%
-96.75%
MORF
LABU

Volatility

MORF vs. LABU - Volatility Comparison

The current volatility for Morphic Holding, Inc. (MORF) is 0.00%, while Direxion Daily S&P Biotech Bull 3x Shares (LABU) has a volatility of 19.69%. This indicates that MORF experiences smaller price fluctuations and is considered to be less risky than LABU based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%50.00%60.00%JuneJulyAugustSeptemberOctoberNovember0
19.69%
MORF
LABU